Form 8-K - Current report:
SEC Accession No. 0001193125-24-001950
Filing Date
2024-01-04
Accepted
2024-01-04 08:14:58
Documents
56
Period of Report
2024-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d555423d8k.htm   iXBRL 8-K 27456
2 EX-99.1 d555423dex991.htm EX-99.1 44354
7 GRAPHIC g555423ex99_1s10g1.jpg GRAPHIC 117211
8 GRAPHIC g555423ex99_1s11g1.jpg GRAPHIC 119482
9 GRAPHIC g555423ex99_1s12g1.jpg GRAPHIC 117194
10 GRAPHIC g555423ex99_1s13g1.jpg GRAPHIC 128598
11 GRAPHIC g555423ex99_1s14g1.jpg GRAPHIC 85234
12 GRAPHIC g555423ex99_1s15g1.jpg GRAPHIC 135812
13 GRAPHIC g555423ex99_1s16g1.jpg GRAPHIC 109195
14 GRAPHIC g555423ex99_1s17g1.jpg GRAPHIC 99701
15 GRAPHIC g555423ex99_1s18g1.jpg GRAPHIC 85781
16 GRAPHIC g555423ex99_1s19g1.jpg GRAPHIC 120674
17 GRAPHIC g555423ex99_1s1g1.jpg GRAPHIC 98772
18 GRAPHIC g555423ex99_1s20g1.jpg GRAPHIC 97704
19 GRAPHIC g555423ex99_1s21g1.jpg GRAPHIC 85951
20 GRAPHIC g555423ex99_1s22g1.jpg GRAPHIC 131272
21 GRAPHIC g555423ex99_1s23g1.jpg GRAPHIC 98211
22 GRAPHIC g555423ex99_1s24g1.jpg GRAPHIC 88103
23 GRAPHIC g555423ex99_1s25g1.jpg GRAPHIC 104682
24 GRAPHIC g555423ex99_1s26g1.jpg GRAPHIC 87295
25 GRAPHIC g555423ex99_1s27g1.jpg GRAPHIC 96390
26 GRAPHIC g555423ex99_1s28g1.jpg GRAPHIC 99865
27 GRAPHIC g555423ex99_1s29g1.jpg GRAPHIC 105867
28 GRAPHIC g555423ex99_1s2g1.jpg GRAPHIC 212282
29 GRAPHIC g555423ex99_1s30g1.jpg GRAPHIC 95485
30 GRAPHIC g555423ex99_1s31g1.jpg GRAPHIC 128437
31 GRAPHIC g555423ex99_1s32g1.jpg GRAPHIC 29047
32 GRAPHIC g555423ex99_1s33g1.jpg GRAPHIC 141148
33 GRAPHIC g555423ex99_1s34g1.jpg GRAPHIC 124487
34 GRAPHIC g555423ex99_1s35g1.jpg GRAPHIC 93079
35 GRAPHIC g555423ex99_1s36g1.jpg GRAPHIC 106730
36 GRAPHIC g555423ex99_1s37g1.jpg GRAPHIC 112550
37 GRAPHIC g555423ex99_1s38g1.jpg GRAPHIC 76059
38 GRAPHIC g555423ex99_1s39g1.jpg GRAPHIC 100810
39 GRAPHIC g555423ex99_1s3g1.jpg GRAPHIC 102444
40 GRAPHIC g555423ex99_1s40g1.jpg GRAPHIC 123391
41 GRAPHIC g555423ex99_1s41g1.jpg GRAPHIC 112056
42 GRAPHIC g555423ex99_1s42g1.jpg GRAPHIC 109168
43 GRAPHIC g555423ex99_1s4g1.jpg GRAPHIC 105873
44 GRAPHIC g555423ex99_1s5g1.jpg GRAPHIC 79289
45 GRAPHIC g555423ex99_1s6g1.jpg GRAPHIC 109824
46 GRAPHIC g555423ex99_1s7g1.jpg GRAPHIC 120119
47 GRAPHIC g555423ex99_1s8g1.jpg GRAPHIC 96397
48 GRAPHIC g555423ex99_1s9g1.jpg GRAPHIC 85331
  Complete submission text file 0001193125-24-001950.txt   6420772

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20240104.xsd EX-101.SCH 3870
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20240104_def.xml EX-101.DEF 14095
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20240104_lab.xml EX-101.LAB 23424
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20240104_pre.xml EX-101.PRE 15128
50 EXTRACTED XBRL INSTANCE DOCUMENT d555423d8k_htm.xml XML 5218
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 24509813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)